0000921895-24-000809.txt : 20240405
0000921895-24-000809.hdr.sgml : 20240405
20240405101405
ACCESSION NUMBER: 0000921895-24-000809
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240402
FILED AS OF DATE: 20240405
DATE AS OF CHANGE: 20240405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mokhtar Firdauz
CENTRAL INDEX KEY: 0001861217
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-13341
FILM NUMBER: 24825061
MAIL ADDRESS:
STREET 1: TRIDENT COURT, 1 OAKCROFT ROAD
STREET 2: CHESSINGTON
CITY: SURREY
STATE: X0
ZIP: KT9 1BD
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TITAN PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000910267
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 943171940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 6502444990
MAIL ADDRESS:
STREET 1: 400 OYSTER POINT BLVD
STREET 2: SUITE 505
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94080
3
1
form313531001mok_04052024.xml
OWNERSHIP DOCUMENT
X0206
3
2024-04-02
0
0000910267
TITAN PHARMACEUTICALS INC
TTNP
0001861217
Mokhtar Firdauz
TRIDENT COURT, 1 OAKCROFT ROAD
CHESSINGTON
SURREY
X0
KT9 1BD
UNITED KINGDOM
1
0
0
0
Common Stock
0
D
No securities are beneficially owned.
/s/ Firdauz Edmin Bin Mokhtar
2024-04-05